Gerard Lozanski

The Ohio State University Wexner Medical Center

Also affiliated with The Ohio State University

MedicineImmunology and MicrobiologyComputer Science

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 6%percentile

0.208Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Development of a distributed international patient data registry for hairy cell leukemia

Leukemia & lymphoma/Leukemia and lymphoma(2022)10.1080/10428194.2022.2109157

Top 65%

0.208DataRank

Top 65%3 citations

Mirela Anghelina, Jasmine Neal, James S. Blachly, Puneet Mathur, Omkar Lele +38 more

Papers

Driven by 24 papers — median percentile 35. Top paper: “Phase II Study of Combination Obinutuzumab, Ibrutinib, and Venetoclax in Treatment-Naïve and Relapsed or Refractory Chronic Lymphocytic Leukemia”.

Phase II Study of Combination Obinutuzumab, Ibrutinib, and Venetoclax in Treatment-Naïve and Relapsed or Refractory Chronic Lymphocytic Leukemia

Journal of Clinical Oncology(2020)10.1200/jco.20.00491

N/A

3.8DataRank · unranked

105 citations

Ying Huang, Amy S. Ruppert, Lynne V. Abruzzo, Barbara L. Andersen, Farrukh T. Awan +14 more

Acalabrutinib plus Obinutuzumab in Treatment-Naïve and Relapsed/Refractory Chronic Lymphocytic Leukemia

Cancer Discovery(2020)10.1158/2159-8290.cd-19-1130

N/A

3.1DataRank · unranked

79 citations

James S. Blachly, Kerry A. Rogers, Seema A. Bhat, Mojgan Jianfar, Gerard Lozanski +11 more

Neutralization of SARS-CoV-2 Omicron sub-lineages BA.1, BA.1.1, and BA.2

Cell Host & Microbe(2022)10.1016/j.chom.2022.04.014

N/A

0.757DataRank · unranked

154 citations

Cong Zeng, Panke Qu, Julia N. Faraone, Yi-Min Zheng, Claire Carlin +11 more

Results of a phase 3 study of IVO vs IO for previously untreated older patients (pts) with chronic lymphocytic leukemia (CLL) and impact of COVID-19 (Alliance).

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.7500

N/A

0.687DataRank · unranked

14 citations

Jun Yin, Jennifer R. Brown, Shira Dinner, Gerard Lozanski, Richard F. Little +15 more

Development of a distributed international patient data registry for hairy cell leukemia

Leukemia & lymphoma/Leukemia and lymphoma(2022)10.1080/10428194.2022.2109157

Top 65%

0.208DataRank

Top 65%3 citations

Mirela Anghelina, Jasmine Neal, James S. Blachly, Puneet Mathur, Omkar Lele +38 more

Neutralization and Stability of SARS-CoV-2 Omicron Variant

bioRxiv (Cold Spring Harbor Laboratory)(2021)10.1101/2021.12.16.472934

N/A

0DataRank · unranked

105 citations

John P. Evans, Panke Qu, Julia N. Faraone, Yi-Min Zheng, Claire Carlin +11 more

Loss of Neutralizing Antibody Response to mRNA Vaccination against SARS-CoV-2 Variants: Differing Kinetics and Strong Boosting by Breakthrough Infection

bioRxiv (Cold Spring Harbor Laboratory)(2021)10.1101/2021.12.06.471455

N/A

0DataRank · unranked

11 citations

Cong Zeng, Claire Carlin, Gerard Lozanski, Linda J. Saif, Eugene M. Oltz +3 more

Enhanced neutralization resistance of SARS-CoV-2 Omicron subvariants BQ.1, BQ.1.1, BA.4.6, BF.7, and BA.2.75.2

Cell Host & Microbe(2022)10.1016/j.chom.2022.11.012

N/A

0DataRank · unranked

281 citations

John P. Evans, Julia N. Faraone, Yi-Min Zheng, Claire Carlin, Mirela Anghelina +11 more

Neutralization of the SARS-CoV-2 Omicron BA.4/5 and BA.2.12.1 Subvariants

New England Journal of Medicine(2022)10.1056/nejmc2206725

N/A

0DataRank · unranked

181 citations

Julia N. Faraone, John P. Evans, Xue Zou, Yi-Min Zheng, Claire Carlin +9 more

Durability of Booster mRNA Vaccine against SARS-CoV-2 BA.2.12.1, BA.4, and BA.5 Subvariants

New England Journal of Medicine(2022)10.1056/nejmc2210546

N/A

0DataRank · unranked

87 citations

Julia N. Faraone, John P. Evans, Yi-Min Zheng, Lianbo Yu, Qin Ma +7 more

Neutralization of the SARS-CoV-2 Deltacron and BA.3 Variants

New England Journal of Medicine(2022)10.1056/nejmc2205019

N/A

0DataRank · unranked

37 citations

Panke Qu, Cong Zeng, Yi-Min Zheng, Claire Carlin, Joseph S. Bednash +8 more

Consensus opinion from an international group of experts on measurable residual disease in hairy cell leukemia

Blood Cancer Journal(2022)10.1038/s41408-022-00760-z

N/A

0DataRank · unranked

23 citations

Robert J. Kreitman, Enrico Tiacci, Leslie A. Andritsos, Versha Banerji, Jacqueline C. Barrientos +40 more

Distinct Neutralizing Antibody Escape of SARS-CoV-2 Omicron Subvariants BQ.1, BQ.1.1, BA.4.6, BF.7 and BA.2.75.2

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.10.19.512891

N/A

0DataRank · unranked

87 citations

John P. Evans, Julia N. Faraone, Yi-Min Zheng, Claire Carlin, Mirela Anghelina +11 more

Differential Evasion of Delta and Omicron Immunity and Enhanced Fusogenicity of SARS-CoV-2 Omicron BA.4/5 and BA.2.12.1 Subvariants

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.05.16.492158

N/A

0DataRank · unranked

21 citations

Julia N. Faraone, John P. Evans, Xue Zou, Yi-Min Zheng, Claire Carlin +9 more

Durability of the Neutralizing Antibody Response to mRNA Booster Vaccination Against SARS-CoV-2 BA.2.12.1 and BA.4/5 Variants

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.07.21.501010

N/A

0DataRank · unranked

7 citations

Julia N. Faraone, John P. Evans, Yi-Min Zheng, Claire Carlin, Gerard Lozanski +5 more

Neutralization escape of Omicron XBB, BR.2, and BA.2.3.20 subvariants

Cell Reports Medicine(2023)10.1016/j.xcrm.2023.101049

N/A

0DataRank · unranked

30 citations

Panke Qu, John P. Evans, Yi-Min Zheng, Claire Carlin, Mirela Anghelina +10 more

Lenalidomide-associated B-cell ALL: clinical and pathologic correlates and sensitivity to lenalidomide withdrawal

Blood Advances(2023)10.1182/bloodadvances.2022009212

N/A

0DataRank · unranked

22 citations

Brian C. Shaffer, Bhavana Bhatnagar, Alice S. Mims, Victoria Klein, Deepika Dilip +9 more

Deconvoluting clonal and cellular architecture in IDH-mutant acute myeloid leukemia

Cell stem cell(2025)10.1016/j.stem.2025.04.012

N/A

0DataRank · unranked

19 citations

Soobeom Lee, Zhengxi Sun, Ronan Chaligné, Sanam Loghavi, Georgios Asimomitis +30 more

Neutralizing antibody against SARS-CoV-2 spike in COVID-19 patients, health care workers, and convalescent plasma donors

JCI Insight(2020)10.1172/jci.insight.143213

N/A

0DataRank · unranked

107 citations

John P. Evans, Rebecca M. Pearson, Panke Qu, Yi-Min Zheng, Richard Robinson +9 more

Alemtuzumab in frontline therapy of adult acute lymphoblastic leukemia: Results of Cancer and Leukemia Group B 10102 (Alliance), a phase 1/2 study

Cancer(2025)10.1002/cncr.35750

N/A

0DataRank · unranked

3 citations

Jun Yin, Gerard Lozanski, Emily Curran, Gregory Malnassy, Krzysztof Mrózek +15 more

Neutralizing antibody against SARS-CoV-2 spike in COVID-19 patients, health care workers and convalescent plasma donors: a cohort study using a rapid and sensitive high-throughput neutralization assay

medRxiv(2020)10.1101/2020.08.02.20166819

N/A

0DataRank · unranked

10 citations

John P. Evans, Rebecca M. Pearson, Panke Qu, Yi-Min Zheng, Richard Robinson +9 more

Neutralization of SARS-CoV-2 Variants of Concern Harboring Q677H

mBio(2021)10.1128/mbio.02510-21

N/A

0DataRank · unranked

47 citations

John P. Evans, Julia N. Faraone, Panke Qu, Yi-Min Zheng, Linda J. Saif +4 more

Hairy cell leukemia and COVID-19 adaptation of treatment guidelines

Leukemia(2021)10.1038/s41375-021-01257-7

N/A

0DataRank · unranked

46 citations

Leslie A. Andritsos, Versha Banerji, Jacqueline C. Barrientos, Seema A. Bhat, James S. Blachly +34 more

Targeted Delivery of BZLF1 to DEC205 Drives EBV-Protective Immunity in a Spontaneous Model of EBV-Driven Lymphoproliferative Disease

Vaccines(2021)10.3390/vaccines9060555

N/A

0DataRank · unranked

8 citations

Eric Brooks, Shelby Sloan, Sarah Schlotter, Frankie Jeney, Claire Hale +14 more

Gerard Lozanski

Indexed papers

Top data-sharing exemplar

Papers